On Monday, Sapphire Foods announced that it raised Rs 1,150 crore funds through a mix of primary and secondary rounds from private equity funds
The startup is backed by Berkshire Hathaway Inc. and Jack Ma's Ant
Business Standard brings you the top headlines this evening
The hotel aggregator, in which SoftBank owns a 46% stake and is one of its biggest bets, has endured months of layoffs, cost cuts and losses during the global health crisis
The initial public offering (IPO) comprises fresh issue of shares worth Rs 1,500 crore and an offer for sale of Rs 3,500 crore by promoter Niyogi Enterprise.
Business Standard brings you top headlines this morning
The initial share sale will conclude on August 12
The U.S. Securities and Exchange Commission (SEC) has stopped processing registrations of U.S. initial public offerings (IPOs) and other sales of securities by Chinese companies
Shares in Didi, which jumped as much as 40% to $12.42 in premarket trading after the report, pared gains after trading opened on Wall Street.
Windlas Biotech, manufacturer of pharmaceutical formulations, on Thursday said it has fixed a price band of Rs 448-460 a share for its initial share-sale. The three-day initial public offer (IPO) will open on August 4 and conclude on August 6, the company announced in a virtual press conference. The IPO comprises fresh issuance of equity shares worth Rs 165 crore and and an offer for sale of up to 5,142,067 equity shares. As a part of the OFS, Vimla Windlass will offload 11.36 lakh equity shares, and investor Tano India Private Equity Fund II will sell 40,06,067 equity shares. At the upper end of the price band, the initial share-sale will fetch Rs 401.53 crore. The proceeds from the IPO will be utilised for purchasing of equipment required for capacity expansion of the facility at Dehradun Plant -IV and addition of injectables dosage capability at the facility at Dehradun Plant-II. It will also be used for funding incremental working capital requirements, repayment/ prepayment o
The Sebi chief said the regulator is examining the minimum shareholding and public float at a concept level.
Business Standard brings you the top stories of this evening
Glenmark Life Sciences is the arm of drug major Glenmark Pharmaceuticals.
Robinhood aims to raise more than $2 billion in its public debut, planned for later this summer
The price range for the offer has been fixed at Rs 1,073-1,083 per share.
The government is moving fast with the IPO, which is said to be India's largest.
The Chinese tech giant, whose apps also include TikTok's Chinese twin Douyin and the news aggregator Toutiao, had kicked off initial preparations for an IPO of its domestic assets
Beijing also said on Tuesday it would strengthen supervision of all Chinese firms listed offshore, a sweeping regulatory shift that triggered a sell-off in U.S.-listed Chinese stocks.
Two companies Clean Science and Technology and GR Infraprojects are headed to the market with their initial share-sale offers next week to raise a little over Rs 2,500 crore cumulatively.
Didi lost as much as 11% of its market value at one point on Friday